Partnering with Receptos
Corporate Partnering is a key component of the Receptos’ strategy to drive best-in-class and first-in-class novel therapeutic candidates directed to high-value GPCR receptors into clinical development. Receptos will also enable select strategic partners to deploy the information-driven GPCR structure based drug discovery technology within their own product portfolios.
Receptos is in active discussions with partners concerning collaboration on both small molecule and antibody drug discovery programs, as well as technology partnerships.
For further information on the Receptos approach to partnering and current opportunities please contact;
, Vice President of Corporate Development